Sunnyvale, CA – January 2, 2002 – The biotechnology industry, notably the DNA chip and other biochip sectors, has made remarkable progress in 2001, which will also carry into 2002. While other technology sectors are showing slow to nominal growth, the biotechnology market will continue to prove strong for both the scientific and financial communities.

A new report from Multimedia Research Group, Inc. and Fuji-Keizai USA, Bio Digital Europe: Market Status and Trends and Future Outlook 2000 – 2010 is a comprehensive market composite for the DNA and biochip industries, including profiles for the major players and emerging companies in Europe that are discovering and engineering new breakthroughs in biotechnology.

Timeline for Adoption
The evolution of the biochip and its developmental progress via current tests and products are explained in detail, as are the driving forces in the industry, including the government grants and development programs shaping companies' strategies. The timeline for adoption is measured in relation to market barriers, such as regulatory and patent issues, all of which are discussed in this report.

Tracking Market Size and Demand
The report also details the size and growth of the DNA chip sector, and forecasts the changes in its product mixture throughout the next decade, including market segment-specific growth forecasts for that same period. Timely 2000 market share breakdowns provide a more current composite of the entire DNA and biochip market.

Includes Composites of Major European Biotech Firms
Major biotechnology firms are profiled from throughout the region: within Germany, BASF Lync Bioscience, Bioleads, and BioMax Informatics GmbH, CyBio, Clondiag, DeveloGen, Evotec Biosystems, Qiagen NV, Interactiva PerkinElmer and Wallace; within the U.K., Antisoma, BioRobotics, Biovation, Chem Ovation, and De Novo Pharmaceuticals, Oxford GlycoScience; ProteoMetrics, Synomics; and within Switzerland, Discovery Technologies, GeneData, Geneva Proteomics, Tecan, and Upstream Solutions GmbH. Several other companies within Europe, and Israel, are also profiled.

Bio Digital Europe: Market Status and Trends and Future Outlook 2000 – 2010 is available for US$998.00. To order or request information, contact Rob Smith at 1-408-453-5553 or rsmith@mrgco.com.

Table of Contents
Order Form